Rating Change
Stifel analysts reiterated a Hold rating on Globus Medical, Inc. (NYSE:GMED) on July 08, 2026.
Rating Change Stifel analysts reiterated a Hold rating on Globus Medical, Inc. (NYSE:GMED) on July 08, 2026. Market Context Globus Medical, Inc.

Stifel analysts reiterated a Hold rating on Globus Medical, Inc. (NYSE:GMED) on July 08, 2026.
Globus Medical, Inc. operates in the Healthcare sector. The stock currently trades at $76.20 with a market capitalization of $11.9B. The stock has gained 33.2% over the past 52 weeks.
Analyst coverage from Stifel provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Globus Medical, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 08, 2026 | Stifel | Hold | N/A |
| Jun 15, 2026 | Piper Sandler | Overweight | N/A |
| May 08, 2026 | RBC Capital | Outperform | N/A |
| May 08, 2026 | Wells Fargo | Overweight | N/A |
| May 08, 2026 | Needham | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View GMED Stock Page
A Hold rating from Stifel reflects the analyst's outlook on Globus Medical, Inc. (NYSE:GMED). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GMED forecast page.
Current market data
NYSE · GMED
$80.48
Up: +$1.22 · +1.51%
Live quote updated
Keep reading
analyst ·
analyst ·
analyst ·
earnings ·